_    ___ ___      _                               
   / \  |_ _/ _ \ ___| |_ _ __ ___  __ _ _ __ ___  ___
  / _ \  | | | | / __| __| '__/ _ \/ _` | '_ ` _ \/ __|
 / ___ \ | | |_| \__ \ |_| | |  __/ (_| | | | | | \__ \
/_/   \_\___\___/|___/\__|_|  \___|\__,_|_| |_| |_|___/

Invidious > Channel > OncLive

OncLive	24500 subscribers    RSS
View channel on YouTube Videos Playlists

YT 3 minutes 2 seconds 26 views Shared 11 hours ago OncLive Dr Mekhail on a Case Study of Early-Stage, Nonmetastatic Lung Cancer YT 1 minute 30 seconds 24 views Shared 12 hours ago OncLive Dr Levy on the Development and Clinical Use of ADCs in NSCLC YT 2 minutes 29 seconds 26 views Shared 1 day ago OncLive Dr Hales on the Use of Post-Operative Radiotherapy in NSCLC

YT 1 minute 58 seconds 43 views Shared 1 day ago OncLive Dr Rodriguez on a Case Study of EGFR-Mutated NSCLC YT 1 minute 37 seconds 45 views Shared 2 days ago OncLive Dr Shields on Key ADRIATIC Trial Data With Adjuvant Durvalumab in LS-SCLC YT 1 minute 40 seconds 29 views Shared 2 days ago OncLive Dr Langer on the Evolution of Adjuvant Immunotherapy in NSCLC

YT 4 minutes 21 seconds 25 views Shared 4 days ago OncLive A Pragmatist's View on Biomarker-Driven Decisions in Oncology: Episode 3 YT 5 minutes 35 seconds 44 views Shared 1 week ago OncLive A Pragmatist's View on Biomarker-Driven Decisions in Oncology: Episode 2 YT 2 minutes 58 seconds 48 views Shared 1 week ago OncLive Dr Banerjee on Bispecific Antibody Treatment De-Escalation Strategies in Relapsed Myeloma

YT 2 minutes 35 seconds 64 views Shared 1 week ago OncLive Dr Mowery on Pembrolizumab Plus Radiation Therapy and Surgery in Soft Tissue Sarcoma YT 3 minutes 47 seconds 76 views Shared 2 weeks ago OncLive Dr Piotrowska on Treatment Sequencing Decisions in HER2-Mutated NSCLC YT 2 minutes 28 seconds 74 views Shared 2 weeks ago OncLive Dr Badami on the Optimal Selection of Second-Line TKIs in ccRCC

YT 3 minutes 8 seconds 40 views Shared 2 weeks ago OncLive Dr Westbrook on Clinical Trials That Have Shaped the Non-ccRCC Treatment Paradigm YT 1 minute 31 seconds 79 views Shared 2 weeks ago OncLive Dr Lee on the Efficacy of Enfortumab Vedotin Plus Pembrolizumab in Urothelial Cancer YT 3 minutes 43 seconds 34 views Shared 2 weeks ago OncLive A Pragmatist's View on Biomarker-Driven Decisions in Oncology: Episode 1

YT 4 minutes 34 seconds 56 views Shared 2 weeks ago OncLive Dr Park on Patient and Disease Factors that Affect Treatment Decisions for mHSPC YT 1 minute 22 seconds 57 views Shared 2 weeks ago OncLive Dr Ghia on a Pooled Analysis of OS Outcomes With Ibrutinib Plus Venetoclax in CLL YT 3 minutes 28 seconds 76 views Shared 3 weeks ago OncLive Dr Tan on the Efficacy and Safety of IO-IO and IO-TKI Combination Regimens in RCC

YT 3 minutes 49 seconds 37 views Shared 3 weeks ago OncLive Molecularly Targeted Therapies in Oncology: Episode 4 YT 32 minutes 59 seconds 1K views Shared 3 weeks ago OncLive Dr. DeVita Discusses "The Death of Cancer" YT 3 minutes 13 seconds 88 views Shared 1 month ago OncLive Molecularly Targeted Therapies in Oncology: Episode 3

YT 3 minutes 9 seconds 102 views Shared 1 month ago OncLive Molecularly Targeted Therapies in Oncology: Episode 2 YT 3 minutes 40 seconds 119 views Shared 1 month ago OncLive Molecularly Targeted Therapies in Oncology: Episode 1 YT 3 minutes 13 seconds 67 views Shared 1 month ago OncLive Dr Grinshpun on Ultra-Sensitive ctDNA Detection in HR+ Early Breast Cancer

YT 1 minute 8 seconds 87 views Shared 1 month ago OncLive Dr Mayer on Niraparib Plus Dostarlimab in ER+ BRCA/PALB2-Mutated Breast Cancer YT 1 minute 5 seconds 118 views Shared 1 month ago OncLive Dr Rozenblit on Pembrolizumab Outcomes by TMB Status in HR+ Metastatic Breast Cancer YT 2 minutes 35 seconds 78 views Shared 1 month ago OncLive Dr Lloyd on the Effects of ESR1 Mutations on Elacestrant Outcomes in HR+ Advanced Breast Cancer

YT 3 minutes 23 seconds 99 views Shared 1 month ago OncLive Dr Ali on the S0221 Trial of Alternative Chemo Dosing Schedules in Breast Cancer YT 1 minute 45 seconds 129 views Shared 1 month ago OncLive Dr Rugo on Elacestrant-Based Combinations in ER+/HER2– Metastatic Breast Cancer YT 57 seconds 50 views Shared 1 month ago OncLive Dr Kaklamani on the Effects of VAF on Elacestrant Outcomes in ER+ Breast Cancer

YT 8 minutes 35 seconds 40 views Shared 1 month ago OncLive ESMO 2024 Lessons in Gynecologic Oncology: Episode 3 YT 39 seconds 79 views Shared 1 month ago OncLive Dr Bardia on T-DXd Efficacy By Pace of Prior CDK4/6 Inhibitor Progression in Breast Cancer YT 6 minutes 41 seconds 42 views Shared 1 month ago OncLive ESMO 2024 Lessons in Gynecologic Oncology: Episode 2

YT 5 minutes 21 seconds 70 views Shared 2 months ago OncLive ESMO 2024 Lessons in Gynecologic Oncology: Episode 1 YT 1 minute 11 seconds 186 views Shared 2 months ago OncLive Dr Harding on the FDA Approval of Zanidatamab for HER2+ Biliary Tract Cancer YT 1 minute 39 seconds 194 views Shared 2 months ago OncLive Dr Janjigian on the FDA Approval of Zolbetuximab for CLDN18.2+ Gastric/GEJ Adenocarcinoma

YT 1 minute 55 seconds 74 views Shared 2 months ago OncLive Dr Reidy-Lagunes on the Evolving NET Treatment Paradigm YT 1 minute 34 seconds 94 views Shared 2 months ago OncLive Dr Kalinsky on the Implications of DESTINY-Breast06 for T-DXd Use in HER2-Ultralow Breast Cancer YT 1 minute 50 seconds 61 views Shared 2 months ago OncLive Dr Singer on Toxicities Associated With First-Line IO/TKI Regimens in RCC

YT 23 minutes 44 seconds 125 views Shared 2 months ago OncLive Park and Graff Explore the Evolving Role of CDK4/6 Inhibitors in Metastatic Breast Cancer YT 5 minutes 34 seconds 27 views Shared 2 months ago OncLive Peer Review Publications in Oncology: Episode 6 YT 1 minute 16 seconds 67 views Shared 2 months ago OncLive Dr Herbst on the Evolution of EGFR Inhibition in Lung Cancer

YT 3 minutes 8 seconds 114 views Shared 2 months ago OncLive Dr Weiss on the Role of Breast Imaging in Breast Cancer Treatment Decision-Making YT 6 minutes 13 seconds 34 views Shared 2 months ago OncLive Drs Leyfman and Stearns Discuss Topics of Interest in Breast Cancer on Day 2 of The 42nd Annual CFS YT 6 minutes 15 seconds 27 views Shared 2 months ago OncLive Drs Harding and Leyfman Discuss Insights into HCC on Day 2 of The 42nd Annual CFS

YT 3 minutes 21 seconds 35 views Shared 2 months ago OncLive Peer Review Publications in Oncology: Episode 5 YT 2 minutes 56 seconds 73 views Shared 2 months ago OncLive Dr Singer on the Efficacy of IO/TKI Doublets in Advanced RCC YT 1 minute 46 seconds 74 views Shared 2 months ago OncLive Dr Dimopoulos on Efficacy Findings From the DREAMM-8 Trial in Multiple Myeloma

YT 2 minutes 45 views Shared 2 months ago OncLive Dr Girard on De Novo and Acquired Resistance Alterations in HER2-Altered NSCLC YT 4 minutes 59 seconds 51 views Shared 2 months ago OncLive Peer Review Publications in Oncology: Episode 4 YT 4 minutes 24 seconds 71 views Shared 2 months ago OncLive Dr Westbrook on the Potential Use of ccRCC Therapies in Non-ccRCC

YT 4 minutes 45 seconds 78 views Shared 3 months ago OncLive Dr Braunstein on Novel Risk Factors for Veno-Occlusive Disease Development YT 4 minutes 8 seconds 27 views Shared 3 months ago OncLive Peer Review Publications in Oncology: Episode 3 YT 3 minutes 6 seconds 113 views Shared 3 months ago OncLive Dr Cristofanilli on Applications for Liquid Biopsy–Based MRD Testing in Breast Cancer

YT 1 minute 15 seconds 151 views Shared 3 months ago OncLive Dr Saad on the Safety Profile of Darolutamide Plus ADT in mHSPC YT 2 minutes 4 seconds 103 views Shared 3 months ago OncLive Dr Inra on the Role of the Surgeon in Early-Stage Lung Cancer YT 2 minutes 57 seconds 121 views Shared 3 months ago OncLive Dr Mok on the Efficacy of Taletrectinib in ROS1+ NSCLC

YT 2 minutes 16 seconds 66 views Shared 3 months ago OncLive Dr Awan on the Evolving Role of Bispecific Antibodies Treatment in DLBCL YT 1 minute 45 seconds 61 views Shared 3 months ago OncLive Dr Bekaii-Saab on Frontline Treatment Considerations for BRCA1/2+ Pancreatic Cancer YT 1 minute 46 seconds 46 views Shared 3 months ago OncLive Dr Mazzoni on the Use of Quadruplet Regimens in Newly Diagnosed Myeloma